Tri-Ad™ 900SFC32Recalls & reported problems
Medtronic, Inc. · RING 900SFC32 TRI-AD ADAMS · Class 2 · Implant
All models of Tri-Ad (12)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 10
- Deaths reported
- 0
- Injuries reported
- 10
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 10 adverse event reports that list this exact device (DI 00643169195370), received between Apr 3, 2017 and Nov 18, 2025 — classified as 10 injuries.
The most frequently reported specific device problem is “Insufficient Device Problem Information” (7 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Most reported problems
Device problems
- Insufficient Device Problem Information7
- Adverse Event Without Identified Device or Use Problem2
- Patient Device Interaction Problem2
- Inadequacy of Device Shape and/or Size1
- Patient-Device Incompatibility1
Patient problems
- No Information6
- Non specific EKG/ECG Changes2
- Tachycardia2
- Tricuspid Regurgitation2
- Atrial Fibrillation1
- Atrial Flutter1
- Bradycardia1
- Complete Heart Block1
Recent adverse event reports
The 10 most recent of 10 reports, in the reporter's own words as published by the FDA.
InjuryNov 18, 2025Patient Device Interaction Problem; Patient Device Interaction Problem
IT WAS REPORTED THAT 3 YEARS AND 5 MONTHS POST IMPLANT OF THIS 32MM TRICUSPID ANNULOPLASTY HEART RING, A DEFIBRILLATOR WAS IMPLANTED. THE REASON FOR THE DEFIBRILLATOR WAS REPORTED AS SYNCOPE WITH INDUCIBLE VENTRICULAR TACHYCARDIA (VT) AND VENTRICULAR FIBRILLATION (VF). NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Syncope/Fainting; Tachycardia; Ventricular Fibrillation
MAUDE report 23580474 ↗InjuryJun 6, 2025Patient Device Interaction Problem; Patient Device Interaction Problem
MEDTRONIC RECEIVED INFORMATION THAT 6 DAYS POST IMPLANT OF THIS TRI-AD RING, A PERMANENT PACEMAKER WAS IMPLANTED. THE REASON FOR THE PERMANENT PACEMAKER WAS REPORTED AS SINUS BRADYCARDIA, ATRIAL TACHYCARDIA, ATRIAL FIBRILLATION AND ATRIAL FLUTTER. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Atrial Fibrillation; Atrial Flutter; Bradycardia; Tachycardia
MAUDE report 22156703 ↗InjuryMay 29, 2020Insufficient Device Problem Information; Insufficient Device Problem Information
MEDTRONIC RECEIVED INFORMATION THAT A 32MM ANNULOPLASTY HEART BAND WAS IMPLANTED IN THE TRICUSPID POSITION AND EXPLANTED ON THE-SAME DAY. IT WAS ALSO REPORTED THAT A REPLACEMENT WAS DONE USING A 33MM BIOPROSTHETIC HEART VALVE. THE REASON FOR REPLACEMENT WAS NOT REPORTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: No Information
MAUDE report 10102850 ↗InjuryMar 25, 2020Patient-Device Incompatibility; Patient-Device Incompatibility
MEDTRONIC RECEIVED INFORMATION THAT IMMEDIATELY POST IMPLANT OF THIS 32MM TRICUSPID ANNULOPLASTY RING, IT WAS EXPLANTED AND REPLACED WITH A 29MM BIOPROSTHETIC VALVE. THERE WERE NO ALLEGATIONS AGAINST THE RING OR ITS FUNCTION. THE PHYSICIAN REPORTED PATIENT ANATOMY ISSUES AND DETERMINED REPLACING THE VALVE WOULD BE BETTER FOR THE PATIENT. NO ADDITIONAL ADVERSE PATIENT WERE REPORTED.
Patient problems: No Information
MAUDE report 9877383 ↗InjuryMay 28, 2019Insufficient Device Problem Information; Insufficient Device Problem Information
MEDTRONIC RECEIVED INFORMATION THAT 5 DAYS POST IMPLANT OF THIS TRICUSPID ANNULOPLASTY RING, A PERMANENT PACEMAKER WAS IMPLANTED DUE TO ATRIO-VENTRICULAR (AV) BLOCK. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Complete Heart Block; Non specific EKG/ECG Changes
MAUDE report 8647446 ↗InjuryJun 25, 2018Insufficient Device Problem Information; Insufficient Device Problem Information
MEDTRONIC RECEIVED INFORMATION THAT DURING THE IMPLANT OF THIS 32MM ANNULOPLASTY RING IN THE TRICUSPID POSITION, THE RING WAS EXPLANTED AND REPLACED FOR UNKNOWN REASONS. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: No Information; Tricuspid Regurgitation
MAUDE report 7635016 ↗InjuryMay 15, 2018Adverse Event Without Identified Device or Use Problem; Insufficient Device Problem Information; Adverse Event Without Identified Device or Use Problem; Insufficient Device Problem Information
MEDTRONIC RECEIVED INFORMATION THAT DURING THE IMPLANT OF THIS ANNULOPLASTY RING, A PERMANENT PACEMAKER WAS IMPLANTED. THE REASON FOR IMPLANT OF A PERMANENT PACEMAKER IS UNKNOWN. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: No Known Impact Or Consequence To Patient; Non specific EKG/ECG Changes
MAUDE report 7514394 ↗InjuryMay 24, 2017Insufficient Device Problem Information; Insufficient Device Problem Information
MEDTRONIC RECEIVED INFORMATION THAT IMMEDIATELY FOLLOWING IMPLANT OF THIS ANNULOPLASTY RING IT WAS REPLACED WITH A BIOPROSTHETIC VALVE DUE TO POOR ECHOCARDIOGRAM RESULTS. THE PHYSICIAN EXPRESSED DISSATISFACTION WITH THE RING. NO SPECIFIC FAILURE MECHANISM WAS PROVIDED. NO OTHER ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: No Information
MAUDE report 6589295 ↗InjuryMay 10, 2017Adverse Event Without Identified Device or Use Problem; Insufficient Device Problem Information; Adverse Event Without Identified Device or Use Problem; Insufficient Device Problem Information
MEDTRONIC RECEIVED INFORMATION THAT ONE YEAR, FOUR MONTHS POST IMPLANT OF THIS ANNULOPLASTY RING IN THE TRICUSPID POSITION, THIS DEVICE WAS EXPLANTED AND REPLACED WITH A BIOPROSTHETIC MITRAL VALVE. NO FAILURE MECHANISM AND NO OTHER ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: No Information; Organ Dehiscence
MAUDE report 6556283 ↗InjuryApr 3, 2017Inadequacy of Device Shape and/or Size; Insufficient Device Problem Information; Inadequacy of Device Shape and/or Size; Insufficient Device Problem Information
MEDTRONIC RECEIVED INFORMATION THAT IMMEDIATELY POST IMPLANT OF THIS TRICUSPID ANNULOPLASTY RING, THIS DEVICE WAS EXPLANTED. NO FAILURE MECHANISM AND NO OTHER ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: No Information; Tricuspid Regurgitation
MAUDE report 6453674 ↗
Other RING, ANNULOPLASTY devices
- CG FUTURE™ 638BL32Medtronic, Inc. · RING, ANNULOPLASTY1 death71 reports
- PROFILE 3D® 680R28Medtronic, Inc. · RING, ANNULOPLASTY1 death67 reports
- CG FUTURE™ 638BL30Medtronic, Inc. · RING, ANNULOPLASTY1 death65 reports
- CG FUTURE™ 638RL32Medtronic, Inc. · RING, ANNULOPLASTY59 reports
- Tri-Ad™ 900SFC228Medtronic, Inc. · RING, ANNULOPLASTY4 deaths56 reports
- CG FUTURE™ 638BL34Medtronic, Inc. · RING, ANNULOPLASTY51 reports
- Contour 3D® 690R30Medtronic, Inc. · RING, ANNULOPLASTY1 death50 reports
- CG FUTURE™ 638BL28Medtronic, Inc. · RING, ANNULOPLASTY1 death47 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page